A 37-year-old woman is seen in a sexual health clinic for the management of recurrent genital herpes simplex virus type 2 (HSV-2). She reports two outbreaks of genital herpes in the past 12 months. She is sexually active with a 33-year-old man who has no history of genital herpes, and he recently had a negative HSV-2 antibody test. She is interested in reducing her risk of transmitting HSV-2 to her partner.
Which one of the following HSV suppressive regimens has been shown to reduce the risk of HSV-2 transmission in this setting?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
March 11th, 2025
March 11th, 2025
Steps to acquire a Certificate for this Lesson:
1
Answer Questions
Answer the board-review style questions
2
Answer Correctly
Score 80%+
3
Give Feedback
Complete survey
4